跳至主要内容
临床试验/NCT01916798
NCT01916798终止3 期

Intravenous Intralipid Therapy Among Women Aged 35-40 Years With Positive Peripheral Blood Natural Killer Cells Undergoing in Vitro Fertilization-Embryo Transfer: A Randomized Controlled Trial.

Cairo University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2013年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
入组人数
200
试验地点
1
主要终点
Clinical pregnancy rate

研究概览

简要总结

Intralipid can suppress natural killer cells that are known to be involve in repeated implantation failure and recurrent miscarriages.Intralipid is made of purified soybean oil, egg phospholipids, glycerol and water. It provides essential fatty acids, linoleic acid, omega- 3 and 6 fatty acids and alpha-linolenic acid. The effects of Intralipid in suppressing natural killer cell activity (NKa) were found to be comparable to intravenous immunoglobulin (IVIG) by laboratory experiments.We will study the effect of intralipid infusion on the pregnancy outcome of women aged 35-40 years with history of repeated implantation failure of miscarriage and who have positive peripheral blood natural killer cells

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Subfertile women aged 35-40 years with repeated implantation failure or recurrent miscarriage with positive natural killer cells undergoing Intracytoplasmic sperm injection (ICSI ) cycle.

排除标准

  • women above 40years or less than 35 years
  • Disturbances of normal fat metabolism such as pathologic hyperlipidemia,Lipoid nephrosis or acute pancreatitis with hyperlipidemia.
  • Allergic to eggs, soybean oil, or safflower oil.
  • Severe liver disease, kidney disease, lung disease, anemia, blood coagulation disorder.
  • Uterine fibroid, endometrial polyp, endometriosis and hydrosalpinx.
  • Antiphospholipid syndrome (lupus anticoagulant and/or anticardiolipin antibodies (Immunoglobulin G or M)[IgG or IgM]); other recognised thrombophilic conditions (testing according to usual clinic practice).
  • Intrauterine abnormalities (as assessed by ultrasound, hysterosonography, hysterosalpingogram, or hysteroscopy).
  • Fibroids distorting uterine cavity.
  • Abnormal parental karyotype.

研究组 & 干预措施

Intralipid infusion

Active Comparator

100 Subfertile women aged 35-40 years with repeated implantation failure or recurrent miscarriage with positive natural killer cells undergoing ICSI cycle.

干预措施: Intralipid infusion (Drug)

结局指标

主要结局

Clinical pregnancy rate

时间窗: 10 months

Intrauterine gestational sac with fatal pole and positive pulsation

次要结局

  • Miscarriage rate(12 months)
  • Chemical pregnancy(10 months)
  • ongoing pregnancy rate(10 months)
  • Ectopic rate(12 months)
  • implantation rate(10 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eman Elkattan

Dr.

Cairo University

研究点 (1)

Loading locations...

相似试验